Morgan Stanley
TMCI icon

Morgan Stanley’s Treace Medical Concepts TMCI Stock Holding History

Morgan Stanley’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.27M Buy
320,026
+100,319
+46% +$276K ﹤0.01% 5099
2026
Q1 		$294K Buy
219,707
+10,984
+5% +$21.9K ﹤0.01% 5704
2025
Q4 		$511K Sell
208,723
-551,586
-73% -$2.4M ﹤0.01% 5505
2025
Q3 		$5.1M Sell
760,309
-259,120
-25% -$1.69M ﹤0.01% 4132
2025
Q2 		$5.99M Sell
1,019,429
-512,714
-33% -$3.34M ﹤0.01% 3909
2025
Q1 		$12.9M Sell
1,532,143
-609,323
-28% -$5.48M ﹤0.01% 3110
2024
Q4 		$15.9M Sell
2,141,466
-1,132,591
-35% -$7.58M ﹤0.01% 2978
2024
Q3 		$19M Buy
3,274,057
+443,027
+16% +$2.85M ﹤0.01% 2848
2024
Q2 		$18.8M Sell
2,831,030
-461,038
-14% -$3.72M ﹤0.01% 2737
2024
Q1 		$43M Buy
3,292,068
+174,334
+6% +$2.32M ﹤0.01% 1897
2023
Q4 		$39.8M Buy
3,117,734
+2,904,228
+1,360% +$29.3M ﹤0.01% 1962
2023
Q3 		$2.8M Sell
213,506
-231,152
-52% -$4.23M ﹤0.01% 4154
2023
Q2 		$11.4M Buy
444,658
+27,944
+7% +$721K ﹤0.01% 3044
2023
Q1 		$10.5M Buy
416,714
+233,531
+127% +$5.48M ﹤0.01% 3097
2022
Q4 		$4.21M Buy
183,183
+94,320
+106% +$2.17M ﹤0.01% 3900
2022
Q3 		$1.96M Buy
88,863
+49,698
+127% +$961K ﹤0.01% 4442
2022
Q2 		$560K Buy
39,165
+18,878
+93% +$318K ﹤0.01% 5357
2022
Q1 		$384K Sell
20,287
-23,998
-54% -$466K ﹤0.01% 5565
2021
Q4 		$826K Buy
44,285
+40,675
+1,127% +$839K ﹤0.01% 5212
2021
Q3 		$97K Buy
3,610
+1,703
+89% +$46.9K ﹤0.01% 6401
2021
Q2 		$59K Buy
+1,907
New +$60.7K ﹤0.01% 6603

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Morgan Stanley's TMCI Position: Q2 2026 in Review

Morgan Stanley increased its Treace Medical Concepts (TMCI) stake by 46% in Q2 2026, buying an estimated $276K and bringing the position to 320,026 shares worth $1.27M. The position accounts for ﹤0.01% of the portfolio, ranked #5099.

Morgan Stanley first reported a position in TMCI in Q2 2021 and has held it in 21 quarters since. The position peaked at $43M in Q1 2024. 117 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Morgan Stanley held 320,026 shares of Treace Medical Concepts worth $1.27M as of Q2 2026.
  • Morgan Stanley bought 100,319 Treace Medical Concepts shares in Q2 2026, an estimated $276K.
  • Treace Medical Concepts made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #5099 holding.
  • Morgan Stanley first reported a position in Treace Medical Concepts in Q2 2021 and has held it in 21 quarters since.
  • Morgan Stanley's Treace Medical Concepts position peaked at $43M in Q1 2024.
  • 117 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.